comparemela.com

Page 5 - Alzecure Pharmaview News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Janet Hoogstraate New Board Member of AlzeCure Pharma

STOCKHOLM, SWEDEN / ACCESSWIRE / May 19, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule

Alzecure pharmaThomas pollareJanet hoogstraateAlzecure pharmaviewAstra zenecaGewinn nurHult international business schoolUniversity of leidenBiopharmaceutical sciencesStockholm brain instituteHult international businessStockholm brainValneva swedenNasdaq first north premier growth market

Report from the Annual General Meeting of AlzeCure Pharma on 17 May 2023

STOCKHOLM, SE / ACCESSWIRE / May 17, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) Today, 17 May 2023, the annual general meeting was held in AlzeCure Pharma AB (publ) (the "Company"). Below is a summary

Thomas pollareGewinn nurAlzecure pharmaviewCamilla nilssonEva lilienbergEllen donnellyAlzecure pharmaRagnar linderAstra zenecaJanet hoogstraateSwedish companiesSwedish companies registration officeUniversity of leidenHult international business schoolBiopharmaceutical sciencesStockholm brain institute

AlzeCure Pharma: AlzeCure Participates at Penser Market on May 25

STOCKHOLM, SE / ACCESSWIRE / May 16, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule

Alzecure pharmaAlzecure pharmaviewDispenser marketNasdaq first north premier growth marketGefallene big techs

AlzeCure Pharma: AlzeCure holds a Capital Markets Day on May 17

STOCKHOLM, SE / ACCESSWIRE / May 11, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR) a pharmaceutical company that develops a broad portfolio of drug candidates

Karolinska institutetJohan sandinAlzecure pharmaDnr johan sandinAlzecure pharmaviewPontus forsellMartin westerbergHead of discovery researchKarolinska instituteCapital markets dayProfessor bengt winbladChief scientificCure pharmaBengt winbladNasdaq first north premier growth marketGefallene big techs

AlzeCure Pharma: AlzeCure Publishes its Interim Report for January

STOCKHOLM, SE / ACCESSWIRE / May 04, 2023 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the period January - March 2023

Alzecure pharmaviewAlzecure pharmaCandidate drugAlzstatin alzheimerAnnual general meetingNasdaq first north premier growth market

vimarsana © 2020. All Rights Reserved.